Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in Endocrine-Resistant Metastatic Breast Cancer
NCT00225758Phase 2Terminated
- Start
- Jan 2006
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer. Started Jan 2006; status: terminated.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00225758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225758.